ONCAlert | Upfront Therapy for mRCC
Videos  >  

Advice to Community Oncologists on Treating Patients With GI Cancers

Tanios Bekaii-Saab, MD
Published Online:3:44 PM, Tue December 11, 2018


Tanios Bekaii-Saab, MD, a professor of medicine at the Mayo Clinic, discusses how community oncologists can play an important role in the advancement of gastrointestinal (GI) cancers despite not having access to major trials.

Now, more than ever, there is a better understanding of alterations, mutations, amplifications, and fusions that are drivers, Bekaii-Saab says. Many studies now are looking at colorectal cancer to develop agents for the various subgroups.

To move the needle forward in GI cancers as a whole, the first step is in colon cancer, Bekaii-Saab explains. For community oncologists, it is important to screen patients using genomic analysis; many platforms for this are commercially available, he notes. The analysis can guide oncologists to find studies for each patient, based on their alterations.
Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.